urinary proteome
Diagnostic TestVolume 2 ml, with protease inhibitor made one time for each arm of the protocol
NCT Number: NCT07285421
In the research, the investigators will characterize the renal and vascular damage and look for factors favoring the formation of calcification induced by enamel renal syndrome.
Patients will undergo four investigations, as part of their routine care, to assess their renal impairment. Each investigation will require a day in the Physiology Department of the George Pompidou European Hospital.
The 4 tests are designed to
* precisely measure your renal filtration capacity, * evaluate your body's calcium and phosphate regulation, * evaluate your capacity to regulate the elimination of water from the body * assess your body's ability to regulate "acid" intake. As part of the research, an additional 20 ml blood sample and a urine sample will be taken during the other samples taken as part of routine care.
Healthy volunteers will undergo blood and urine tests, dental X-rays and renal ultrasound. For healthy volunteers, the aim of the dental X-ray and renal ultrasound is to check that there are no dental or renal abnormalities, so as to rule out not only email-rein syndrome, but also any dental or renal abnormalities that might resemble it. The aim of blood and urine sampling is to measure various molecules that promote calcification or inhibit the calcification process, so as to be able to compare results obtained in healthy subjects with those obtained in patients with enamel renal syndrome. Each healthy subject will be selected to be matched by age and sex to each of the patients included in the study.
Trial opening soon.
Get Notified18 year–90 year
All sexes
Interventional
Not applicable
HEGP - clinical investigation center, Paris, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Volume 2 ml, with protease inhibitor made one time for each arm of the protocol
Sample collected once in the protocol for each arm.
Complementary plasma analysis during another blood sample collection for both arms
Other names: Propensity score, Osteoprotegerin, dp-uc MGP, Fetuin A
Verification of normal renal morphology, absence of nephrocalcinosis
Verification of normal dentition
Fasting blood: creatinine, blood ions (Na + K + Cl + CO2 + Proteins), calcium, phosphate, CBC (Complete Blood Count), liver function tests, lipid profile); Morning fasting urine: creatinine, calcium, phosphate, protein, urinalysis (ECBU)
Time frame: Up to 18 months
Glomerular filtration rate measurement by measure of renal 99mTc-DTPA clearance
Time frame: Up to 18 months
Identification of candidate mechanisms to approach the pathophysiology of ectopic calcifications through the study of the urinary proteome
Time frame: Up to 18 months
Evaluation of water regulation by water deprivation test, urine collection after deprivation.
Time frame: Up to 18 months
Identification of candidate mechanisms for approaching the pathophysiology of ectopic calcifications by assaying plasma inhibitors of biomineralization.
Time frame: Up to 18 months
Identification of candidate mechanisms for approaching the pathophysiology of ectopic calcifications by assaying plasma inhibitors of biomineralization.
Time frame: Up to 18 months
Identification of candidate mechanisms for approaching the pathophysiology of ectopic calcifications by assaying plasma inhibitors of biomineralization.
Time frame: Up to 18 months
Identification of candidate mechanisms for approaching the pathophysiology of ectopic calcifications by assaying plasma inhibitors of biomineralization.
Time frame: Up to 18 months
Urine collection to evaluate the acid regulation after oral ammonium chloride load test.
Time frame: Up to 18 months
Urine collection in order to evaluate calcium regulation.
Time frame: Up to 18 months
Blood and urine collection in order to evaluate phosphate regulation
Time frame: Up to 18 months
Thoracic, abdominal and pelvic scan perform in order to evaluate vascular calcium content.
Contact information is provided by the study sponsor or research team.
Assistance Publique - Hôpitaux de Paris
Other
Acronym: FAM-Cal
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.